Microbiota I-Center, also known as MagIC, is a leading brand committed to revolutionizing microbiome diagnostics and therapeutics. Their mission is to position Hong Kong as a world-class hub for microbiome biotechnology. By harnessing the power of the human microbiome, MagIC develops innovative solutions for early disease detection and prevention.

The focus of MagIC lies in advancing research in the gut microbiome while fostering entrepreneurship. Their groundbreaking approach involves the development of microbiome diagnostics and live biotherapeutics for common diseases such as obesity, cancer, autism, inflammatory disorders, and even COVID-19. These breakthroughs not only transform the lives of patients and their families but also accelerate Hong Kong's growth in the field of microbiome biotechnology.

With the knowledge that our bodies consist of 30 trillion human cells and a staggering 39 trillion microbial cells, the possibilities for improving health outcomes through the manipulation of our gut microbiome are immense. Microbiome Medicine, as MagIC terms it, offers hope for understanding who we are, what we can potentially become, and most importantly, the ability to positively impact our fate. MagIC collaborates with renowned clinician researchers and institutions globally to unlock the full potential of the microbiome.

Their expertise, technology, and research services are at the forefront of clinical diagnostics and intestinal microbiota transplantation. Furthermore, MagIC actively supports the development of spin-out companies and offers internship opportunities for aspiring individuals interested in making a difference in the field of microbiome biotechnology. For those looking to stay updated with MagIC's groundbreaking work, they can follow the brand on social media or get in touch via email.

Microbiota I-Center is undoubtedly driving innovation and paving the way for a healthier future through the power of the microbiome